2006
DOI: 10.1021/bi061005x
|View full text |Cite
|
Sign up to set email alerts
|

Evolution of New Function in the GTP Cyclohydrolase II Proteins of Streptomyces coelicolor

Abstract: The genome sequence of Streptomyces coelicolor contains three open reading frames (sco1441, sco2687, and sco6655) that encode proteins with significant (>40%) amino acid identity to GTP cyclohydrolase II (GCH II), which catalyzes the committed step in the biosynthesis of riboflavin. The physiological significance of the redundancy of these proteins in S. coelicolor is not known. However, the gene contexts of the three proteins are different, suggesting that they may serve alternate biological niches. Each of t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
29
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(31 citation statements)
references
References 49 publications
(90 reference statements)
2
29
0
Order By: Relevance
“…Till now, various biochemical and structural studies have been done to understand the molecular mechanism of GCHII and its role in riboflavin biosynthesis pathway (Fassbinder et al, 2000;Foor and Brown, 1975;Kaiser et al, 2002;Ren et al, 2005;Schramek et al, 2001;Spoonamore et al, 2006). We have characterized GCHII from H. pylori (hGCHII) to design inhibitors against this essential enzyme, which could be developed further as potential anti-bacterial drug.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Till now, various biochemical and structural studies have been done to understand the molecular mechanism of GCHII and its role in riboflavin biosynthesis pathway (Fassbinder et al, 2000;Foor and Brown, 1975;Kaiser et al, 2002;Ren et al, 2005;Schramek et al, 2001;Spoonamore et al, 2006). We have characterized GCHII from H. pylori (hGCHII) to design inhibitors against this essential enzyme, which could be developed further as potential anti-bacterial drug.…”
Section: Discussionmentioning
confidence: 99%
“…GCHII has been studied in many organisms (Bereswill et al, 1998;Herz et al, 2000;Oltmanns et al, 1969;Spoonamore et al, 2006;Zakal'skii et al, 1990) and detailed biochemical and structural characterization has been done from Escherichia coli (E. coli) (Kaiser et al, 2002;Ren et al, 2005;Ritz et al, 2001;Schramek et al, 2001). Crystal structure of GCHII has been reported in mono-functional and bi-functional form from E. coli (eGCHII) (Ren et al, 2005) and Mycobacterium tuberculosis (M. tuberculosis) (mGCHII) (Singh et al, 2013) respectively.…”
Section: Introductionmentioning
confidence: 99%
“…The enzyme properties were studied in the bacteria E. coli (35,123,206), B. subtilis (185), Helicobacter pylori (32), and Streptomyces coelicolor (461), the flavinogenic yeast P. guilliermondii (412,418,425), and the model plant Arabidopsis thaliana (174 (206,365). The reaction starts by pyrophosphate release, which appeared to be the rate-limiting step of the overall reaction, after which imidazole ring opening and elimination of formate occur (206,373).…”
Section: Gtp Cyclohydrolases II and Iiimentioning
confidence: 99%
“…Archaea and some eubacteria also contain another GTP cyclohydrolase, GTP cyclohydrolase III, which catalyzes the conversion of GTP to 2-amino-5-formylamino-6-ribosylamino-4(3H)-pyrimidinone 5-phosphate, i.e., the formylated derivative of the product of GTP cyclohydrolase II (151,181,461). In other words, GTP cyclohydrolase III, in contrast to GTP cyclohydrolase II, hydrolyzes the imidazole ring of GTP but does not remove the resulting formyl group from the formamide.…”
Section: Gtp Cyclohydrolases II and Iiimentioning
confidence: 99%
See 1 more Smart Citation